Clinical evaluation of the Sthaulyahara effect of Haritaki and Amalaki based on the principle of Hrasa Hetur Visheshascha

Abstract

Sthoulya is one of the most effective disease which affects someone social, physical and mental features. As per modern view, it is a precursor to coronary heart disease, high blood pressure, diabetic mellitis and osteoarthritis which have been recognised as the leading killer diseases of the millennium. Sthoulya is a state of increased Vikruta Vruddhi of Medodhatu. It is one of the Santarponottha Vikaras where a physician needs to apply the principle of Vishesha which can restore the unhealthy increase of components to the previous undiseased form. The drug Haritaki and Amalaki are having Laghu and Rooksha Guna which are opposite Gunas to that of the Sthoulya. Objectives - Practical evaluation of the Sthaulyahara effect of Haritaki and Amalkai based on the principle of Hrasa Hetur Visheshascha. Results - 60 patients (92%) had completed the trial, no adverse effect were reported. Both the groups had improved in the clinical trials, overall statistical significance was observed in the scores of both the groups. Discussion - By this statistical result we can concluded that Group A patients were more releived than Group B who were administered Haritaki Choorna. The hypothesis decided for the study was ‘Vishesha’ is the prime cause for Hrasa. Here it was clear that Vishesha applied was Guna Vishesha. Here significant results itself shows that Vishesha has done its role in reducing the obesity (Hrasa) in better way in both the Groups.